STX12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.519400E-01
Normal-vs-Stage2
5.246200E-01
Normal-vs-Stage3
1.337650E-01
Normal-vs-Stage4
2.363000E-01
Stage1-vs-Stage2
9.137000E-01
Stage1-vs-Stage3
2.477800E-01
Stage1-vs-Stage4
5.231800E-02
Stage2-vs-Stage3
3.047200E-01
Stage2-vs-Stage4
3.341800E-03
Stage3-vs-Stage4
3.138000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.305400E-01
Normal-vs-AfricanAmerican
8.289200E-01
Normal-vs-Asian
1.492770E-01
Caucasian-vs-AfricanAmerican
1.690210E-01
Caucasian-vs-Asian
1.695200E-01
AfricanAmerican-vs-Asian
9.861800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.472600E-01
Normal-vs-Female
7.144800E-01
Male-vs-Female
1.863240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.630600E-01
Normal-vs-Age(41-60Yrs)
9.728200E-01
Normal-vs-Age(61-80Yrs)
4.520600E-01
Normal-vs-Age(81-100Yrs)
1.187640E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.093800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.667200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.883400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.597500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.105700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.250400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.183000E-01
Normal-vs-Daily Drinker
2.689200E-01
Normal-vs-Weekly Drinker
5.855400E-01
Normal-vs-Occasional Drinker
9.230200E-01
Normal-vs-Social Drinker
7.082000E-01
Non Drinker-vs-Daily Drinker
3.910200E-01
Non Drinker-vs-Weekly Drinker
2.223600E-01
Non Drinker-vs-Occasional Drinker
4.863700E-03
Non Drinker-vs-Social Drinker
1.095370E-01
Daily Drinker-vs-Weekly Drinker
5.996000E-01
Daily Drinker-vs-Occasional Drinker
5.586100E-02
Daily Drinker-vs-Social Drinker
3.816800E-01
Weekly Drinker-vs-Occasional Drinker
3.363400E-01
Weekly Drinker-vs-Social Drinker
7.892400E-01
Occasional Drinker-vs-Social Drinker
5.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.513200E-01
Normal-vs-Grade 2
1.191170E-01
Normal-vs-Grade 3
6.565400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.209000E-01
Grade 1-vs-Grade 3
9.353800E-01
Grade 1-vs-Grade 4
3.513200E-01
Grade 2-vs-Grade 3
8.861500E-02
Grade 2-vs-Grade 4
1.191170E-01
Grade 3-vs-Grade 4
6.565400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.835600E-01
Normal-vs-NonDiabetic
4.049800E-01
Diabetic-vs-NonDiabetic
6.831800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.122960E-01
Normal-vs-NoPancreatitis
4.731000E-01
Pancreatitis-vs-NoPancreatitis
1.653750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.502400E-01
Normal-vs-N1
5.740000E-01
N0-vs-N1
8.346400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.718600E-01
Normal-vs-TP53-NonMutant
5.404800E-01
TP53-Mutant-vs-TP53-NonMutant
5.520800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
